GlassScriptPhysician profile
Brenda E Moriarty
NPI 1417610908
$5,126.62
in general payments reported to CMS, 2019-2025
36 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $1,898 · 2023: $2,420 · 2024: $501 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,032.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $636.39 | 2021-2024 | |
| Abbvie INC. | $635.92 | 2022-2025 | |
| Lilly USA, LLC | $297.11 | 2021-2024 | Emgality, Reyvow, Amyvid |
| Neurocrine Biosciences, INC. | $268.24 | 2022-2024 | Ingrezza, Ongentys |
| Ucb, INC. | $261.39 | 2021-2024 | Fintepla, Briviact, Nayzilam |
| Otsuka America Pharmaceutical, INC. | $236.12 | 2023-2024 | Nuedexta, Rexulti |
| Jazz Pharmaceuticals INC. | $233.21 | 2022-2024 | |
| Pfizer INC. | $215.93 | 2023-2024 | |
| Amgen INC. | $215.54 | 2022-2024 | Aimovig |
| Sumitomo Pharma America, INC. | $197.55 | 2023-2024 | Aptiom |
| Upsher-Smith Laboratories LLC | $172.38 | 2021-2022 | |
| Allergan, INC. | $170.65 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $169.80 | 2022 | |
| Lundbeck LLC | $163.18 | 2022-2023 | Vyepti, Rexulti |
| Sunovion Pharmaceuticals INC. | $127.96 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $122.25 | 2022-2023 | |
| Ge Healthcare | $106.21 | 2022-2023 | |
| Fresenius Kabi USA, LLC | $94.14 | 2025 | Smoflipid |
| Catalyst Pharmaceuticals, INC. | $91.28 | 2023 | Fycompa |
| Acorda Therapeutics, INC | $83.95 | 2023 | Inbrija |
| Teva Pharmaceuticals USA, INC. | $76.11 | 2023-2024 | Austedo Xr, Ajovy |
| Argenx US, INC. | $71.66 | 2023-2024 | Vyvgart Hytrulo, Vyvgart |
| Collegium Pharmaceutical, INC. | $63.68 | 2022 | |
| Harmony Biosciences LLC | $55.82 | 2022 | |
| Neurelis, INC. | $53.04 | 2022-2023 | Valtoco |
| Greenwich Biosciences, INC. | $48.59 | 2021 | |
| Scilex Pharmaceuticals INC. | $48.48 | 2023 | Ztlido |
| Amneal Pharmaceuticals LLC | $46.05 | 2023-2024 | Rytary |
| Merck Sharp & Dohme LLC | $40.60 | 2022-2023 | Belsomra |
| Aquestive Therapeutics, INC. | $20.00 | 2022 | |
| Azurity Pharmaceuticals, INC. | $19.71 | 2023 | Horizant |
| Avion Pharmaceuticals | $19.00 | 2022 | |
| Merz Pharmaceuticals, LLC | $17.53 | 2024 | Xeomin |
| Currax Pharmaceuticals LLC | $17.43 | 2022 | |
| Kyowa Kirin, INC. | $16.80 | 2024 | Nourianz |
| Idorsia Pharmaceuticals US INC | $12.92 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Moriarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.